Functional Analysis of cis-Acting Elements Regulating the Alternative Splicing of Human CFTR Exon 9
Open Access
- 1 December 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 8 (13) , 2339-2349
- https://doi.org/10.1093/hmg/8.13.2339
Abstract
The rate of exon 9 exclusion from the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA is associated with monosymptomatic forms of cystic fibrosis. Exon 9 alternative splicing is modulated by a polymorphic polythymidine tract within its 3′ splice site. We have generated a minigene carrying human CFTR exon 9 with its flanking intronic sequences and set up an invivo model to study the cis-acting DNA elements which modulate its splicing. Transfections into human cell lines showed that T5, but not T9 or T7 alleles, significantly increases the alternative splicing of exon 9. Moreover, we found that another polymorphic locus juxtaposed upstream of the T tract, and constituted by (TG)n repeats, can further modulate exon 9 skipping but only when activated by the T5 allele. Then, we extended our studies to the mouse CFTR exon 9 which does not show alternative splicing. Comparison of human and mouse introns 8 and 9 revealed a low homology between the two sequences and the absence of the human polymorphic loci within the mouse intron 3′ splice site. We have tested a series of constructs where the whole human exon 9 with its flanking intronic sequences was replaced partially or completely by the murine counterpart. The transfections of these constructs in human and murine cell lines reveal that also sequences of the downstream intron 9 affect exon 9 definition and co-modulate, with the UG/U 3′ splice site sequences, the extent of exon 9 skipping in CFTR mRNA.Keywords
This publication has 30 references indexed in Scilit:
- Allergic Bronchopulmonary AspergillosisAnnual Review of Medicine, 1999
- Chronic pancreatitis and mutations of the cystic fibrosis geneGut, 1999
- Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.Journal of Clinical Investigation, 1998
- Cystic fibrosis transmembrane conductance regulator gene mutations in severe nasal polyposisClinical Otolaryngology, 1997
- Distinct spectrum of CFTR gene mutations in congenital absence of vas deferensHuman Genetics, 1997
- CFTR Gene Mutations in Adults with Disseminated BronchiectasisPublished by Wiley ,1997
- Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas DeferensNew England Journal of Medicine, 1995
- Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasisHuman Molecular Genetics, 1995
- Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNANature Genetics, 1993
- The Relation between Genotype and Phenotype in Cystic Fibrosis — Analysis of the Most Common Mutation (ΔF508)New England Journal of Medicine, 1990